372 related articles for article (PubMed ID: 31209181)
21. Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines.
Chien WW; Le Beux C; Rachinel N; Julien M; Lacroix CE; Allas S; Sahakian P; Cornut-Thibaut A; Lionnard L; Kucharczak J; Aouacheria A; Abribat T; Salles G
Sci Rep; 2015 Jan; 5():8068. PubMed ID: 25626693
[TBL] [Abstract][Full Text] [Related]
22. Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines.
Parmentier JH; Maggi M; Tarasco E; Scotti C; Avramis VI; Mittelman SD
Leuk Res; 2015 Jul; 39(7):757-62. PubMed ID: 25941002
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic tumor sensitivity to plasma L-asparagine starvation.
Dufour E; Gay F; Aguera K; Scoazec JY; Horand F; Lorenzi PL; Godfrin Y
Pancreas; 2012 Aug; 41(6):940-8. PubMed ID: 22513289
[TBL] [Abstract][Full Text] [Related]
24. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M;
Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
[TBL] [Abstract][Full Text] [Related]
25. Serum asparaginase activities and asparagine concentrations in the cerebrospinal fluid after a single infusion of 2,500 IU/m(2) PEG asparaginase in children with ALL treated according to protocol COALL-06-97.
Vieira Pinheiro JP; Wenner K; Escherich G; Lanvers-Kaminsky C; Würthwein G; Janka-Schaub G; Boos J
Pediatr Blood Cancer; 2006 Jan; 46(1):18-25. PubMed ID: 15929133
[TBL] [Abstract][Full Text] [Related]
26. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
Hermanova I; Zaliova M; Trka J; Starkova J
Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
[TBL] [Abstract][Full Text] [Related]
27. Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F).
Ardalan N; Akhavan Sepahi A; Khavari-Nejad RA
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1137-1147. PubMed ID: 33906306
[TBL] [Abstract][Full Text] [Related]
28. Polyoxazoline-Conjugated l-Asparaginase: An Antibody-Production-Free Therapeutic Agent for Acute Lymphoblastic Leukemia.
Yamada T; Ishimaru M; Shoji T; Tomiyasu H; Tochinai R; Taguchi K; Komatsu T
ACS Appl Bio Mater; 2023 Dec; 6(12):5789-5797. PubMed ID: 38047730
[TBL] [Abstract][Full Text] [Related]
29. Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.
Aslanian AM; Fletcher BS; Kilberg MS
Biochem J; 2001 Jul; 357(Pt 1):321-8. PubMed ID: 11415466
[TBL] [Abstract][Full Text] [Related]
30. Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia.
Bushman JE; Palmieri D; Whinna HC; Church FC
Leuk Res; 2000 Jul; 24(7):559-65. PubMed ID: 10867129
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia.
Ben Tanfous M; Sharif-Askari B; Ceppi F; Laaribi H; Gagné V; Rousseau J; Labuda M; Silverman LB; Sallan SE; Neuberg D; Kutok JL; Sinnett D; Laverdière C; Krajinovic M
Clin Cancer Res; 2015 Jan; 21(2):329-34. PubMed ID: 24907114
[TBL] [Abstract][Full Text] [Related]
32. In silico engineering of L-asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukemia.
Ln R; Doble M; Rekha VP; Pulicherla KK
J Pediatr Hematol Oncol; 2011 Dec; 33(8):617-21. PubMed ID: 22042278
[TBL] [Abstract][Full Text] [Related]
33. Towards development of biobetter: L-asparaginase a case study.
Tripathy RK; Anakha J; Pande AH
Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130499. PubMed ID: 37914146
[TBL] [Abstract][Full Text] [Related]
34. Levels of L-asparagine in CSF after intramuscular administration of asparaginase from Erwinia in children with acute lymphoblastic leukemia.
Dibenedetto SP; Di Cataldo A; Ragusa R; Meli C; Lo Nigro L
J Clin Oncol; 1995 Feb; 13(2):339-44. PubMed ID: 7844595
[TBL] [Abstract][Full Text] [Related]
35. L-glutaminase and L-asparaginase by extracorporeal route in acute lymphoblastic leukemia therapy.
Giordano C; Esposito R; Mazzola G; Vecchio G; Pluvio M; Cirillo D; Capasso GB; Buonanno G
Int J Artif Organs; 1981 Sep; 4(5):244-8. PubMed ID: 6947966
[TBL] [Abstract][Full Text] [Related]
36. Asparagine Synthetase Is Highly Expressed at Baseline in the Pancreas Through Heightened PERK Signaling.
Mukherjee A; Ahmed N; Rose FT; Ahmad AN; Javed TA; Wen L; Bottino R; Xiao X; Kilberg MS; Husain SZ
Cell Mol Gastroenterol Hepatol; 2020; 9(1):1-13. PubMed ID: 31421261
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the asparagine synthetase level in leukemia cells by monoclonal antibodies.
Kusano-Arai O; Iwanari H; Mochizuki Y; Nakata H; Kodama T; Kitoh T; Hamakubo T
Hybridoma (Larchmt); 2012 Oct; 31(5):325-32. PubMed ID: 23098298
[TBL] [Abstract][Full Text] [Related]
38. Rational engineering and insight for a L-glutaminase activity reduced type II L-asparaginase from Bacillus licheniformis and its antileukemic activity in vitro.
Zhou Y; Shen J; Chi H; Zhu X; Lu Z; Lu F; Zhu P
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128690. PubMed ID: 38092107
[TBL] [Abstract][Full Text] [Related]
39. Preliminary in vivo evaluation of the protein transduction domain-modified ATTEMPTS approach in enhancing asparaginase therapy.
Li YT; Kwon YM; Spangrude GJ; Liang JF; Chung HS; Park YJ; Yang VC
J Biomed Mater Res A; 2009 Oct; 91(1):209-20. PubMed ID: 18814276
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response.
Nakamura A; Nambu T; Ebara S; Hasegawa Y; Toyoshima K; Tsuchiya Y; Tomita D; Fujimoto J; Kurasawa O; Takahara C; Ando A; Nishigaki R; Satomi Y; Hata A; Hara T
Proc Natl Acad Sci U S A; 2018 Aug; 115(33):E7776-E7785. PubMed ID: 30061420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
